Cartesian Therapeutics (RNAC) Tax Rate (2021 - 2022)
Cartesian Therapeutics' (RNAC) quarterly Tax Rate came in at 5.14% in Q4 2022, down 625.0% year-on-year from 0.98% in Q4 2021, and down 231.48% on a QoQ basis from 3.91% in Q3 2022.
Cartesian Therapeutics (RNAC) Tax Rate (2021 - 2022) Analysis & Trends
Cartesian Therapeutics (RNAC) has 2 years of Tax Rate data on file, last reported at 5.14% in Q4 2022.
- On a quarterly basis, Tax Rate fell 625.0% year-over-year to 5.14% in Q4 2022; TTM through Dec 2022 was 73.75%, a 65763.0% decrease from a year earlier, with the FY2025 full-year figure at 6.6%, up 698.0% from the prior year.
- Tax Rate for Q4 2022 stood at 5.14%, down from 3.91% in the prior quarter.
- Over the last five years, Tax Rate for RNAC reached as high as 3.91% in Q3 2022 and fell as low as 766.12% in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -5.14% |
| Dec 31, 2022 | -5.14% |
| Dec 31, 2022 | -5.14% |
| Sep 30, 2022 | 3.91% |
| Sep 30, 2022 | 3.91% |
| Sep 30, 2022 | 3.91% |
| Dec 31, 2021 | 1.11% |
| Dec 31, 2021 | 1.11% |
| Dec 31, 2021 | 1.11% |
| Sep 30, 2021 | -766.12% |
| Sep 30, 2021 | -766.12% |
| Sep 30, 2021 | -766.12% |